Profil
Dr. Mikel P.
Moyer is Vice President-Molecular Discovery at Raze Therapeutics, Inc.
Dr. Moyer was previously employed as Chief Scientific Officer by Loxo Oncology, Inc., Vice President-Molecular Discovery by Epizyme, Inc., Medicinal Chemist by Abbott Laboratories, a Principal by Pfizer Inc., and Director-Medicinal Chemistry by The Broad Institute, Inc.
He received his undergraduate degree from the University of Michigan and a doctorate degree from the University of California, Berkeley.
Anciens postes connus de Mikel P. Moyer
| Sociétés | Poste | Fin |
|---|---|---|
| LOXO ONCOLOGY INC | Directeur Technique/Scientifique/R&D | 28/10/2014 |
| EPIZYME, INC. | Corporate Officer/Principal | 01/04/2014 |
Raze Therapeutics, Inc.
Raze Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops oncology therapeutics | Corporate Officer/Principal | - |
| ABBOTT LABORATORIES | Corporate Officer/Principal | - |
| PFIZER INC. | Corporate Officer/Principal | - |
Formation de Mikel P. Moyer
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Abbott Laboratories
Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Epizyme, Inc.
Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers | Health Technology |
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology Engages in research and development in bio medicals to cure infectious disease, cancer, psychiatric research and cardiovascular diseases | Health Technology |
Loxo Oncology, Inc.
Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicine for cancer treatment | Health Technology |
Raze Therapeutics, Inc.
Raze Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops oncology therapeutics | Health Technology |
















